Literature DB >> 27579745

Laser therapy in wound healing associated with diabetes mellitus - Review.

Raquel Gomes de Sousa1, Keila de Nazaré Madureira Batista1.   

Abstract

OBJECTIVE: To determine the most effective parameter in healing wounds related to diabetes mellitus, as well as the most widely used type of laser.
METHODOLOGY: consisted of bibliographic searching the databases Bireme, SciELO, PubMed/Medline and Lilacs by using the keywords related to the topic. Were selected from these keywords, papers discussing the use of laser on wounds associated with diabetes, published in the period 2005-2014, in Portuguese or English.
RESULTS: After analyzing the research, 12 studies consistent with the theme were selected.
CONCLUSION: Based on this review, the studies that showed more satisfactory results in healing diabetic wounds were those who applied energy densities in the range of 3-5 J/cm2, power densities equal to or below 0.2 W/cm2 and continuous emission. The He-Ne laser with a wavelength of 632.8 nm was used more often.

Entities:  

Mesh:

Year:  2016        PMID: 27579745      PMCID: PMC4999108          DOI: 10.1590/abd1806-4841.20163778

Source DB:  PubMed          Journal:  An Bras Dermatol        ISSN: 0365-0596            Impact factor:   1.896


INTRODUCTION

Diabetes mellitus (DM) comprises a set of metabolic diseases resulting from changes in the secretion and/or action of insulin produced by the pancreas. Its main feature is the hyperglycemia associated with dysfunction of various systems, such as cardiovascular, renal and nervous.[1] After tissue injury, scarring occurs through four phases: hemostasis, inflammation, proliferation and remodeling. These phases involve a cascade of events that will add and promote the repair of the lesion. The action of growth factors such as VEGF (Vascular Endothelial Growth Factor), FGF (fibroblast growth factor) and TGF-β (Transforming Growth Factor β) is essential since it stimulates fibroblast proliferation and collagen, as well as the neovascularization, important for scar formation. When any of these components is changed, there is a commitment of tissue repair and the wound becomes chronic. [2] In diabetic subjects, there is an endothelial dysfunction, which alters the performance of these cells, such as the proliferation, migration and angiogenesis ability, hampering the consolidation of this process. [3] This dysregulation, associated with the presence of neuropathy and consequent reduction in sensitivity, predisposes the emergence of ulcers. [4] The deficiency in the wound healing process is a complex problem not only for the diabetic patient and family, but also for the government, since the high-risk of the existing infection may culminate in the patient's limb and own life impairment, burdening the system with social security expenses. [5-6] Due to this dysfunction, several studies have been conducted aiming to assist in wound healing of patients and to reduce morbidity and mortality caused by them. Among the reported therapeutic methods, there is the Low Level Laser Therapy (LLLT). The low level laser therapy is considered an effective therapeutic method in wound healing when certain factors are properly observed, such as dosage, power input, time and interval between sessions. [7] It promotes the reduction of the inflammatory phase, favoring the angiogenesis and the production of extracellular matrix components, as well as its organization.[8-9] In addition to reducing the lesion area and accelerating the healing process, laser therapy has the advantage of being easily administered. These benefits assist in promoting patient quality of life and minimizing possible complications. [10-11] Research conducted in vitro and in vivo, aiming at wound healing by LLLT, have different protocols. The types of low intensity lasers often found in the literature are Helium and Neon (He-Ne), Gallium-Aluminum-Arsenide (GaAlAs) Aluminum-Gallium-Indium-Phosphorous (AlGaInP) and Gallium-Arsenide (GaAs).[12] Parameters such as energy density, power, wave shape and length, beam and application time show wide divergence between studies. Dosage appears as one of the most disparate, ranging from 0.04 to 30 J/cm2.[12,13] The densities used can often be inappropriate for the phase in which the wound is. In wound healing in diabetes, different doses will promote the stimulation or inhibition of this process. Thus, it is important to note, among the most commonly used protocols, which ones proved to be beneficial, so the effectiveness of photostimulation is not compromised. [14] The random use of these parameters for the same purpose highlights the need for standardization in laser therapy. The objective of this study, therefore, was to check the most effective parameter in the healing of wounds associated with diabetes mellitus, as well as the most commonly used type of laser.

METHODOLOGY

We conducted a literature search in the databases Bireme, Scielo, Pubmed/ Medline and Lilacs through the combination of descriptors laser therapy, low level, diabetic foot, foot ulcer and wound healing. From these keywords, we selected articles addressing the use of low intensity laser in wounds associated with diabetes, published between 2005-2014, in Portuguese or English, with full text available for access. All articles that did not meet the above inclusion criteria, as well as literature reviews and studies analyzing laser therapy by light emitting diodes (LEDs), were excluded from this research.

RESULTS

After analysis of the research, we selected 12 studies compatible with the theme, depicted in table 1.
Table 1

Low-intensity laser use in wounds associated with diabetes mellitus (2005-2014)

StudyAuthor(s)/ YearSampleDiabetic group treatedType of laserPower densitiyEnergy densityApplication timeEmission formWavelenghtBeam
1Maiya et al., 2005[15]Total sample: 48 maleN=24He-Ne______*4.8 J/cm2______*Continuous632.8 nmVisible
Wistar mice        
2Carvalho et al., 2006[16]Total sample: 48 maleN=12He-Ne0.2 W/cm24 J/cm260sContinuous632.8 nmVisible
Wistar mice        
3Houreld, Abrahamse, 2007[17]Sample: Cell culture of human skin fibroblasts______*He-Ne2.206 mW/ cm25 J/cm237minContinuous632.8 nmVisible
   16 J/cm22h   
Diabetic cells        
4Gungormus¸Akyol, 2009[19]Total sample: 36 femaleN=18GaAlAs0.1W/cm210 J/cm2______*Continuous808nmInvisible
Wistar mice        
5Maiya et al., 2009[14]Total sample: 192 maleN=168He-Ne0.01 W/cm23-9 J/cm23 -27 minContinuous632.8 nmVisible
Wistar mice        
6Carvalho et al., 2010[8]Total sample: 30 maleN=15GaAlAs______*10 J/ cm224 sContinuous660 nmVisible
Wistar mice        
7Noudeh et al., 2010[24]Total sample: 19 maleN=5AlGaInP______*10 J/cm248 sContinuous670nmVisible
Wistar mice GaAlAs 1.33 J/cm250 s 810nmInvisible
8Hegde et al., 2011[18]Total sample: 105 maleN=35He-Ne4.02 mW/cm21-5 J/cm24-21 minContinuous632.8 nmVisible
Swiss mice        
9Ayuk et al., 2012[22]Sample: Cell culture of human skin fibroblasts______*______*10.22 mW/cm25 J/ cm28 min 9 sContinuous660nmVisible
10Rocha et al., 2012[21]Total sample: 30 non-obese diabetic mice (NOD)N=7GaAs15mW/cm23.8 J/ cm220 sPulsed780 nmInvisible
11Khoo et al., 2014[23]Total sample: 14. Cell culture of the skin of diabetic and non-diabetic miceN=7GaAlAs10 mW/cm21 J/ cm21 min and 40 sContinuous810 nmInvisible
12Kilík et al., 2014[20]Total sample: 48 male miceN=24GaAlAs1 mW/ cm25 J/cm283 min 20 sContinuous635 nmVisible
 5mW/ cm2 16 min 40 s   
 15mW/ cm2 5 min 33 s   
Low-intensity laser use in wounds associated with diabetes mellitus (2005-2014)

DISCUSSION

Among the selected studies, five presented experiments with He-Ne laser. Results obtained by the authors showed improvement in the healing process of wounds associated with DM, with increased collagen synthesis, fibroblast proliferation, angiogenesis and re-epithelialization. However, the parameters used were quite diverse, including studies using GaAlAs (4), AlGaInP (2) and GaAs (1). Maiya et al (2005) used He-Ne laser at a dose of 4.8 J/cm2 and a distance of 6 mm from the wound, applied for five days a week until complete healing in diabetic rats, and found an increase in the tissue repair rate. [15] Moreover, Carvalho et al (2006), using daily an approximate dose (4 J/cm2), showed that laser therapy can influence the percentage of collagen fibers, increasing their quantity both in diabetic and in control groups.[16] In the study by Houreld and Abrahamse (2007), two energy densities were tested: 5 J/cm2 for 37 minutes or 16 J/cm2 for 2 hours. [17] They found that the irradiation of 5 J/ cm2 is capable of stimulating the expression of IL-6 (interleukin-6) and cell proliferation and migration of fibroblasts of diabetic wounds. On the other hand, diabetic wounds cells irradiated with 16 J/cm2 demonstrated signs of cell damage, presenting inhibitory effect. Maiya et al (2009) also compared the effect of different dosages (3-9 J/cm2) and found that healing was significantly accelerated in the groups receiving irradiation of 3-6 J/cm2 per day, being even more effective in the group irradiated with 4-5 J/cm2. [14] Doses between 7 and 9 J/cm2 showed mild deceleration of the healing process and are considered bioinhibitories in diabetic wounds. Similarly, Hegde et al (2011) applied energy densities of 1-5 J/cm2 and elected 3 J/cm2 as the best one for wound healing. [18] In contrast, Gungormus and Akyol (2009), using GaAlAs diode at a dose of 10 J/cm2 with power density of 0.1 W/cm2, demonstrated an increase in re-epithelialization rate in the diabetic group treated with an interval of two days between applications.[19] Benefits such as increased collagen and macrophages of diabetic wounds were also obtained with the same dosage in the study by Carvalho et al (2010), [8] but using AlGaInP and application of 24 s. In order to verify the action of different power densities in the wound healing of diabetic and nondiabetic mice, Kilik et al (2014), after irradiation with GaAlAs and daily dose of 5 J/cm2, observed a significant neovascularization in the groups irradiated with power densities of 5 and 15 mW/cm2, as well as synthesis and organization of collagen fibers and reduced inflammatory response.[20] Rocha et al (2012), also using a power of 15 mW/cm2, but with GaAs diode at a dose of 3.8 J/cm2, showed that low-intensity laser irradiation at an interval of 48 hours is able to downmodulate the expression of the enzyme cyclooxygenase 2, contributing to the control of the inflammatory response in skin lesions of NOD mice.[21] The stimulation of the healing process has also been demonstrated in studies by Ayuk et al (2012) and Khoo et al (2014). [22,23] Both used low-dose (5:01 J/cm2), with approximate power densities (10.22 mW/cm2 and 10 mW/cm2), but there was a wide variation in other parameters, such as application time and wavelength. However, the study by Noudeh et al (2010), a combination of the AlGaInP and GaAlAs diodes, with a dose of 10 J/cm2 (48 s) and 1.33 J/cm2 (50 s), respectively, with an interval of three days between sessions, did not achieve significant results in the control group.[24]

CONCLUSION

Based on this review, the studies that presented better results in diabetic wounds healing were those that applied energy densities in the range of 3-5 J/cm2, power densities ≤0.2 W/cm2, and continuous emission. He-Ne laser with a wavelength of 632.8 nm was the most widely used.
  19 in total

1.  Effect of low intensity helium-neon (He-Ne) laser irradiation on diabetic wound healing dynamics.

Authors:  G Arun Maiya; Pramod Kumar; Laxmi Rao
Journal:  Photomed Laser Surg       Date:  2005-04       Impact factor: 2.796

2.  Effect of low-level laser therapy (λ660 nm) on angiogenesis in wound healing: a immunohistochemical study in a rodent model.

Authors:  Fábio Colombo; Alberto de Aguiar Pires Valença Neto; Ana Paula Cavalcanti de Sousa; Antônio Márcio Teixeira Marchionni; Antônio Luiz Barbosa Pinheiro; Silvia Regina de Almeida Reis
Journal:  Braz Dent J       Date:  2013

3.  [In hospital care for diabetic foot: a comparison between the estimated cost and the SUS reimbursement].

Authors:  Karla F Rezende; Marco A P Nunes; Naira H Melo; Domingos Malerbi; Antônio R Chacra; Marco B Ferraz
Journal:  Arq Bras Endocrinol Metabol       Date:  2008-04

4.  Collagen production in diabetic wounded fibroblasts in response to low-intensity laser irradiation at 660 nm.

Authors:  Sandra M Ayuk; Nicolette N Houreld; Heidi Abrahamse
Journal:  Diabetes Technol Ther       Date:  2012-10-11       Impact factor: 6.118

5.  A combination of 670 nm and 810 nm diode lasers for wound healing acceleration in diabetic rats.

Authors:  Younes Jahangiri Noudeh; Mohammad Shabani; Nasibeh Vatankhah; Seyyed Jafar Hashemian; Karim Akbari
Journal:  Photomed Laser Surg       Date:  2010-10       Impact factor: 2.796

6.  Influence of ingaalp laser (660nm) on the healing of skin wounds in diabetic rats.

Authors:  Paulo de Tarso Camillo de Carvalho; Iandara Schettert da Silva; Filipe Abdalla dos Reis; Daniel Martins Perreira; Ricardo Dutra Aydos
Journal:  Acta Cir Bras       Date:  2010-02       Impact factor: 1.388

7.  Effect of biostimulation on wound healing in diabetic rats.

Authors:  Metin Güngörmüş; Utkan Kamil Akyol
Journal:  Photomed Laser Surg       Date:  2009-08       Impact factor: 2.796

Review 8.  Shedding light on a new treatment for diabetic wound healing: a review on phototherapy.

Authors:  Nicolette N Houreld
Journal:  ScientificWorldJournal       Date:  2014-01-06

9.  Effect of equal daily doses achieved by different power densities of low-level laser therapy at 635 nm on open skin wound healing in normal and diabetic rats.

Authors:  Róbert Kilík; Lucia Lakyová; Ján Sabo; Peter Kruzliak; Kamila Lacjaková; Tomáš Vasilenko; Martina Vidová; František Longauer; Jozef Radoňak
Journal:  Biomed Res Int       Date:  2014-01-16       Impact factor: 3.411

10.  In vitro Therapeutic Effects of Low Level Laser at mRNA Level on the Release of Skin Growth Factors from Fibroblasts in Diabetic Mice.

Authors:  Nooshafarin Kazemi Khoo; Mohammad Ali Shokrgozar; Iraj Ragerdi Kashani; Amir Amanzadeh; Ehsan Mostafavi; Hassan Sanati; Laleh Habibi; Saeid Talebi; Morteza Abouzaripour; Seyed Mohammad Akrami
Journal:  Avicenna J Med Biotechnol       Date:  2014-04
View more
  6 in total

1.  A randomized controlled trial comparing helium-neon laser therapy and infrared laser therapy in patients with diabetic foot ulcer.

Authors:  Sayed A Tantawy; Walid K Abdelbasset; Dalia M Kamel; Saud M Alrawaili
Journal:  Lasers Med Sci       Date:  2018-05-30       Impact factor: 3.161

2.  Comparative study on laser and LED influence on tissue repair and improvement of neuropathic symptoms during the treatment of diabetic ulcers.

Authors:  Natália Aguiar Moraes Vitoriano; Daniela Gardano Bucharles Mont'Alverne; Maria Iara Socorro Martins; Priscila Sampaio Silva; Cristiany Azevedo Martins; Hortência Diniz Teixeira; Camylla Bandeira Miranda; Leila Maria Machado Bezerra; Renan Magalhães Montenegro; José Carlos Tatmatsu-Rocha
Journal:  Lasers Med Sci       Date:  2019-02-04       Impact factor: 3.161

3.  Effects of Buprenorphine, Chlorhexidine, and Low-level Laser Therapy on Wound Healing in Mice.

Authors:  Donna R Webb; Sheba R Churchill; Georgette D Hill; Christopher A McGee; Min Shi; Angela P King-Herbert; Terry L Blankenship-Paris
Journal:  Comp Med       Date:  2021-04-16       Impact factor: 0.982

Review 4.  Update on management of diabetic foot ulcers.

Authors:  Estelle Everett; Nestoras Mathioudakis
Journal:  Ann N Y Acad Sci       Date:  2018-01       Impact factor: 5.691

Review 5.  Use of electroanalgesia and laser therapies as alternatives to opioids for acute and chronic pain management.

Authors:  Paul F White; Ofelia Loani Elvir Lazo; Lidia Galeas; Xuezhao Cao
Journal:  F1000Res       Date:  2017-12-21

6.  Inhibition of autophagy promoted high glucose/ROS-mediated apoptosis in ADSCs.

Authors:  Qiang Li; Yating Yin; Yuqing Zheng; Feifei Chen; Peisheng Jin
Journal:  Stem Cell Res Ther       Date:  2018-10-25       Impact factor: 6.832

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.